To Evaluate Whether IVUS-guided Drug-eluting Stent (DES) Implantation Leads to Better Clinical Outcomes Compared to Conventional Angiography in the Treatment of Chronic Complete Occlusion (CTO) Disease.

NARecruitingINTERVENTIONAL
Enrollment

1,448

Participants

Timeline

Start Date

October 21, 2022

Primary Completion Date

October 31, 2031

Study Completion Date

October 31, 2031

Conditions
Chronic Total Occlusion of Coronary Artery
Interventions
PROCEDURE

The guidewire successfully passed the CTO lesion

"The successful passage of the guide wire through the CTO lesion was defined as: the guide wire successfully passed through the CTO lesion and reached the distal true lumen as confirmed by angiography.~Aspirin load dose (300 mg), clopidogrel load dose (300 mg), or ticagrelor load dose (180 mg) is recommended for all subjects prior to stent implantation and is recommended to be taken at least 6 hours prior to surgery."

Trial Locations (1)

Unknown

RECRUITING

General Hospital of Shenyang Military Region, Beijing

All Listed Sponsors
collaborator

BSC International Medical Trading (Shanghai) Co., Ltd.

OTHER

lead

CCRF Inc., Beijing, China

INDUSTRY